The most predictive cell type contexts for nominating therapeutic targets of IBD are CD4+ αβ memory T cells, enterocytes of epithelium of large intestine, T follicular helper cells, plasmablasts, and myeloid dendritic cells (Figure 5d). Here, CD4 is linked to inflammatory bowel disease.